Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$337M |
| 2 |
Pfizer
PFE
|
+$315M |
| 3 |
Chevron
CVX
|
+$266M |
| 4 |
Procter & Gamble
PG
|
+$236M |
| 5 |
JPMorgan Chase
JPM
|
+$221M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Healthcare | 13.11% |
| 3 | Technology | 12.26% |
| 4 | Consumer Discretionary | 9.3% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Cinemark Holdings
CNK
$4.45B
| $3.96M | 0.01% |
+141,822
| New | +$4.15M |
|
|
WWAV.B
877
DELISTED
THE WHITEWAVE FOODS COMPANY CLASS B COM STK
WWAV.B
| $3.96M | 0.01% |
+260,482
| New | +$4.28M |
|
|
RHT
878
DELISTED
Red Hat Inc
RHT
| $3.96M | 0.01% |
+82,701
| New | +$4.03M |
|
879
Wipro
WIT
$18.6B
| $3.94M | 0.01% |
+2,890,459
| New | +$4.29M |
|
880
Omega Healthcare
OHI
$14.1B
| $3.93M | 0.01% |
+126,763
| New | +$4.17M |
|
|
DHC
881
Diversified Healthcare Trust
DHC
$1.94B
| $3.92M | 0.01% |
+152,577
| New | +$4.14M |
|
|
TIVO
882
DELISTED
Tivo Inc
TIVO
| $3.87M | 0.01% |
+169,500
| New | +$3.97M |
|
|
AGU
883
DELISTED
Agrium
AGU
| $3.87M | 0.01% |
+44,500
| New | +$4.06M |
|
884
The Ensign Group
ENSG
$10.5B
| $3.87M | 0.01% |
+430,270
| New | +$3.84M |
|
885
Celanese
CE
$4.97B
| $3.86M | 0.01% |
+86,124
| New | +$4.05M |
|
|
SCLN
886
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $3.85M | 0.01% |
+775,400
| New | +$3.69M |
|
887
Arch Capital
ACGL
$34.5B
| $3.84M | 0.01% |
+224,037
| New | +$3.9M |
|
888
PetMed Express
PETS
$37.9M
| $3.83M | 0.01% |
+304,100
| New | +$3.96M |
|
|
TCO
889
DELISTED
Taubman Centers Inc.
TCO
| $3.83M | 0.01% |
+50,988
| New | +$4.16M |
|
|
ECYT
890
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $3.83M | 0.01% |
+291,580
| New | +$3.93M |
|
|
BMR
891
DELISTED
BIOMED REALTY TRUST INC
BMR
| $3.83M | 0.01% |
+189,116
| New | +$4.09M |
|
|
NUVA
892
DELISTED
NuVasive, Inc.
NUVA
| $3.82M | 0.01% |
+154,200
| New | +$3.37M |
|
893
Insperity
NSP
$1.99B
| $3.82M | 0.01% |
+252,030
| New | +$3.67M |
|
|
CPN
894
DELISTED
Calpine Corporation
CPN
| $3.81M | 0.01% |
+179,325
| New | +$3.76M |
|
895
Teradata
TDC
$2.56B
| $3.76M | 0.01% |
+74,862
| New | +$4.03M |
|
896
CubeSmart
CUBE
$9.21B
| $3.75M | 0.01% |
+234,854
| New | +$3.84M |
|
897
UMB Financial
UMBF
$10.9B
| $3.75M | 0.01% |
+67,349
| New | +$3.43M |
|
|
GWRU
898
DELISTED
GENESEE & WYOMING INC TANGIBLE EQUITY UNIT (DE)
GWRU
| $3.73M | 0.01% |
+31,075
| New | +$3.82M |
|
899
Flowers Foods
FLO
$1.54B
| $3.72M | 0.01% |
+168,696
| New | +$3.7M |
|
900
Sunstone Hotel Investors
SHO
$2.1B
| $3.72M | 0.01% |
+307,858
| New | +$3.75M |
|
Similar funds
Cliff Asness's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Cliff Asness, which disclosed 2,329 positions worth $28.2B. Its ten largest holdings account for 8.5% of the portfolio.
Its largest position is ExxonMobil: 3,744,346 shares worth $338M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, followed by Healthcare and Technology.
- Cliff Asness's largest Q2 2013 buy was ExxonMobil: 3,744,346 shares worth $338M.
- Cliff Asness's ten largest holdings make up 8.5% of its $28.2B portfolio in Q2 2013.
- Cliff Asness disclosed 2,329 positions in Q2 2013, its first 13F filing on record.
Based on AQR Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.